The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus.

Metabolites · 2022 · PMC8876688 · PMID 35208225

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In pristane-induced SLE, CDDO-Im decreased classic (pro-inflammatory) macrophages (CMs) and showed an increasing trend for pro-resolving non-classic macrophages (NCMs).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.